Literature DB >> 16695017

INVESTIGATIONS OF MENINGOCOCCAL INFECTION. III. THE BACTERICIDAL ACTION OF NORMAL AND IMMUNE SERA FOR THE MENINGOCOCCUS.

L Thomas1, J H Dingle.   

Abstract

Year:  1943        PMID： 16695017      PMCID： PMC435250          DOI： 10.1172/JCI101406

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  INVESTIGATIONS OF MENINGOCOCCAL INFECTION. I. BACTERIOLOGICAL ASPECTS.

Authors:  L Thomas; J H Dingle
Journal:  J Clin Invest       Date:  1943-05       Impact factor: 14.808

2.  INVESTIGATIONS OF MENINGOCOCCAL INFECTION. II. IMMUNOLOGICAL ASPECTS.

Authors:  L Thomas; H W Smith; J H Dingle
Journal:  J Clin Invest       Date:  1943-05       Impact factor: 14.808
  2 in total
  16 in total

1.  Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis.

Authors:  K T Mountzouros; A P Howell
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  INVESTIGATIONS OF MENINGOCOCCAL INFECTION. I. BACTERIOLOGICAL ASPECTS.

Authors:  L Thomas; J H Dingle
Journal:  J Clin Invest       Date:  1943-05       Impact factor: 14.808

3.  INVESTIGATIONS OF MENINGOCOCCAL INFECTION. II. IMMUNOLOGICAL ASPECTS.

Authors:  L Thomas; H W Smith; J H Dingle
Journal:  J Clin Invest       Date:  1943-05       Impact factor: 14.808

4.  Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

Authors:  S E Maslanka; L L Gheesling; D E Libutti; K B Donaldson; H S Harakeh; J K Dykes; F F Arhin; S J Devi; C E Frasch; J C Huang; P Kriz-Kuzemenska; R D Lemmon; M Lorange; C C Peeters; S Quataert; J Y Tai; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

5.  Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes.

Authors:  D E Craven; K T Shen; C E Frasch
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.

Authors:  Kenneth T Mountzouros; Kelly A Belanger; Alan P Howell; Garvin S Bixler; Dace V Madore
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 7.  Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.

Authors:  Von Vergel L Torres; Carrie F Coggon; Timothy J Wells
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 8.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

9.  Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera.

Authors:  Dan M Granoff; Jo Anne Welsch; Sanjay Ram
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

10.  Bactericidal action of fresh rabbit blood against Brucella abortus.

Authors:  R W Joos; W H Hall
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.